Global Active Pharmaceutical Ingredients Market 2015-2019

Global Active Pharmaceutical Ingredients Market 2015-2019

Category : Pharmaceuticals
Published On : December  2014
Pages : 119



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Active Pharmaceutical Ingredients
Active pharmaceutical ingredients are the active substances that are used in the manufacture of a drug and have a pharmacological effect. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. Active pharmaceutical ingredients may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology, respiratory disorders, and rheumatoid arthritis.
TechNavio's analysts forecast the Global Active Pharmaceutical Ingredients market to grow at a CAGR of 7.48 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Active Pharmaceutical Ingredients market during the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of active pharmaceutical ingredients by vendors in the market. The report provides the vendor landscape and a corresponding detailed analysis of the top seven vendors in the market. The market segmentation data and analysis is also provided for the following segmentation types: type of production process, type of product, type of player, and geography.
In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, the Global Active Pharmaceutical Ingredients Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.
Key Regions
• Americas
• APAC
• EMEA   
Key Vendors
• Aurobindo Pharma
• BASF
• Boehringer Ingelheim
• Cipla
• Dr. Reddy's Laboratories
• Lonza Group
• Teva Pharmaceutical Industries
Other Prominent Vendors
 
• Abbott Laboratories
• Actavis
• Aesica
• Albemarle
• AMPAC Fine Chemicals
• Anhui Biochem United Pharmaceutical
• Anuh Pharma
• Aptuit
• AstraZeneca
• Biocon
• Bristol-Myers Squibb
• Calyx Chemicals & Pharmaceuticals
• Cambrex
• Cilag
• CIRON Drugs and Pharmaceuticals
• CTX Life Sciences
• Dishman Pharmaceuticals & Chemicals
• Dr. Paul Lohmann
• Emcure Pharmaceuticals
• Farmabios
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Guilin Pharmaceutical
• Hetero Drugs
• Hospira
• Ipca Laboratories
• Janssen Pharmaceutica
• Johnson Matthey
• Laurus Labs
• Lupin
• Mallinckrodt Pharmaceuticals
• Mangalam Drugs & Organics
• Merck
• Mylan
• Novartis
• Novasep
• Pen Tsao Chemical Industry
• Pfizer
• Ranbaxy Laboratories
• Royal DSM
• Sanofi-Aventis
• Sequent Scientific
• Shanghai Desano Chemical Pharmaceutical
• Shasun
• Shijiazhuang Lonzeal Pharmaceuticals
• Sigma-Aldrich
• ST Pharm
• Sun Pharmaceutical Industries
• WuXi AppTec
• Zhejiang Langhua Pharmaceutical
• Zhuhai Rundu Pharmaceutical
 

Market Driver
• Increase in Outsourcing Activities
• For a full, detailed list, view our report
Market Challenge
• Decrease in R&D Spending
• For a full, detailed list, view our report
Market Trend
• Emergence of Africa
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
07. Global Active Pharmaceutical Ingredients Market
07.1 Market Size and Forecast
07.2 Five Forces Analysis
08. Market Segmentation by Type of Production Process
08.1 Global Market for Synthetically Produced Active Pharmaceutical Ingredients
08.1.1 Market Size and Forecast
08.2 Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients
08.2.1 Market Size and Forecast
08.2.2 Market Segmentation by Type of Product
09. Market Segmentation by Type of Product
09.1 Global High-potency Active Pharmaceutical Ingredients Market
09.1.1 Market Size and Forecast
09.1.2 Market Segmentation by Type of Production Process
09.1.3 Market Segmentation by Type of Product
10. Market Segmentation by Type of Player
10.1 Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product
11. Geographical Segmentation
11.1 Active Pharmaceutical Ingredients Market in Americas
11.1.1 Market Size and Forecast
11.2 Active Pharmaceutical Ingredients Market in APAC Region
11.2.1 Market Size and Forecast
11.3 Active Pharmaceutical Ingredients Market in EMEA Region
11.3.1 Market Size and Forecast
12. Key Leading Countries
13. Buying Criteria
14. Market Growth Drivers
15. Drivers and their Impact
16. Market Challenges
17. Impact of Drivers and Challenges
18. Market Trends
19. Trends and their Impact
20. Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.2 Key Vendors 2014
20.3 Other Prominent Vendors
20.3.1 Abbott Laboratories
20.3.2 Actavis
20.3.3 Aesica
20.3.4 Albemarle
20.3.5 AMPAC Fine Chemicals
20.3.6 Anhui Biochem United Pharmaceutical
20.3.7 Anuh Pharma
20.3.8 Aptuit
20.3.9 AstraZeneca
20.3.10 Biocon
20.3.11 Bristol-Myers Squibb
20.3.12 Calyx Chemicals & Pharmaceuticals
20.3.13 Cambrex
20.3.14 Cilag
20.3.15 CIRON Drugs and Pharmaceuticals
20.3.16 CTX Life Sciences
20.3.17 Dishman Pharmaceuticals & Chemicals
20.3.18 Dr. Paul Lohmann
20.3.19 Emcure Pharmaceuticals
20.3.20 Farmabios
20.3.21 F. Hoffmann-La Roche
20.3.22 GlaxoSmithKline
20.3.23 Guilin Pharmaceutical
20.3.24 Hetero Drugs
20.3.25 Hospira
20.3.26 Ipca Laboratories
20.3.27 Janssen Pharmaceutica
20.3.28 Johnson Matthey
20.3.29 Laurus Labs
20.3.30 Lupin
20.3.31 Mallinckrodt Pharmaceuticals
20.3.32 Mangalam Drugs & Organics
20.3.33 Merck
20.3.34 Mylan
20.3.35 Novartis
20.3.36 Novasep
20.3.37 Pen Tsao Chemical Industry
20.3.38 Pfizer
20.3.39 Ranbaxy Laboratories
20.3.40 Royal DSM
20.3.41 Sanofi-Aventis
20.3.42 Sequent Scientific
20.3.43 Shanghai Desano Chemical Pharmaceutical
20.3.44 Shasun
20.3.45 Shijiazhuang Lonzeal Pharmaceuticals
20.3.46 Sigma-Aldrich
20.3.47 ST Pharm
20.3.48 Sun Pharmaceutical Industries
20.3.49 WuXi AppTec
20.3.50 Zhejiang Langhua Pharmaceutical
20.3.51 Zhuhai Rundu Pharmaceutical
21. Key Vendor Analysis
21.1 Aurobindo Pharma
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation
21.1.4 Geographical Segmentation by Revenue 2014
21.1.5 Business Strategy
21.1.6 Recent Developments
21.1.7 SWOT Analysis
21.2 BASF
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business/Product Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Boehringer Ingelheim
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 Cipla
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Product Segmentation
21.4.4 Geographical Segmentation by Revenue 2014
21.4.5 Business Strategy
21.4.6 Recent Developments
21.4.7 SWOT Analysis
21.5 Dr. Reddy's Laboratories
21.5.1 Key Facts
21.5.2 Business Overview
21.5.3 Business Segmentation by Revenue 2014
21.5.4 Business Segmentation by Revenue 2013 and 2014
21.5.5 Geographical Segmentation by Revenue 2014
21.5.6 Business Strategy
21.5.7 Recent Developments
21.5.8 SWOT Analysis
21.6 Lonza Group
21.6.1 Key Facts
21.6.2 Business Overview
21.6.3 Business Segmentation by Revenue 2013
21.6.4 Business Segmentation by Revenue 2012 and 2013
21.6.5 Geographical Segmentation by Revenue 2013
21.6.6 Business Strategy
21.6.7 Recent Developments
21.6.8 SWOT Analysis
21.7 Teva Pharmaceutical Industries
21.7.1 Key Facts
21.7.2 Business Overview
21.7.3 Business Segmentation
21.7.4 Business Segmentation by Revenue 2013
21.7.5 Business Segmentation by Revenue 2012 and 2013
21.7.6 Sales by Geography
21.7.7 Business Strategy
21.7.8 Key Developments
21.7.9 SWOT Analysis
22. Other Reports in this Series

?
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Active Pharmaceutical Ingredients Market Segmentation
Exhibit 3: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process
Exhibit 4: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product
Exhibit 5: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player
Exhibit 6: Global Active Pharmaceutical Ingredients Market Segmentation by Geography
Exhibit 7: Global Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 8: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 9: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014-2019
Exhibit 10: Global Market for Synthetically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 11: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients 2014-2019 (US$ billion)
Exhibit 12: Global Market for Biotechnologically Produced Active Pharmaceutical Ingredients: Segmentation by Type of Product 2014
Exhibit 13: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 14: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014-2019
Exhibit 15: Global High-potency Active Pharmaceutical Ingredients Market 2014-2019 (US$ billion)
Exhibit 16: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Production Process 2014
Exhibit 17: Global High-potency Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 18: Global Active Pharmaceutical Ingredients Market Segmentation by Type of Player 2014
Exhibit 19: Global Merchant Active Pharmaceutical Ingredients Market Segmentation by Type of Product 2014
Exhibit 20: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014
Exhibit 21: Global Active Pharmaceutical Ingredients Market Segmentation by Geography 2014-2019
Exhibit 22: Active Pharmaceutical Ingredients Market in Americas 2014-2019 (US$ billion)
Exhibit 23: Active Pharmaceutical Ingredients Market in Americas: Segmentation by Key Leading Country 2014
Exhibit 24: Active Pharmaceutical Ingredients Market in APAC Region 2014-2019 (US$ billion)
Exhibit 25: Active Pharmaceutical Ingredients Market in APAC Region: Segmentation by Key Leading Country 2014
Exhibit 26: Active Pharmaceutical Ingredients Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 27: Active Pharmaceutical Ingredients Market in EMEA Region: Segmentation by Key Leading Countries 2014
Exhibit 28: Global Active Pharmaceutical Ingredients Market: Key Leading Countries 2014
Exhibit 29: WHO's List of Prequalified Active Pharmaceutical Ingredients (22nd October, 2014)
Exhibit 30: Aurobindo Pharma: Business Segmentation
Exhibit 31: Aurobindo Pharma: Geographical Segmentation by Revenue 2014
Exhibit 32: BASF: Business Segmentation 2013
Exhibit 33: BASF: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: BASF: Geographical Segmentation by Revenue 2013
Exhibit 35: Boehringer Ingelheim: Business Segmentation by Revenue 2013
Exhibit 36: Boehringer Ingelheim: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 37: Boehringer Ingelheim: Geographical Segmentation by Revenue 2013
Exhibit 38: Cipla: Product Segmentation
Exhibit 39: Cipla: Geographical Segmentation by Revenue 2014
Exhibit 40: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2014
Exhibit 41: Global Active Pharmaceutical Ingredients Market: Business Segmentation by Revenue 2013 and 2014 (US$ billion)
Exhibit 42: Dr. Reddy's Laboratories: Geographical Segmentation by Revenue 2014
Exhibit 43: Lonza Group: Business Segmentation by Revenue 2013
Exhibit 44: Lonza Group: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 45: Lonza Group: Geographical Segmentation by Revenue 2013
Exhibit 46: Teva Pharmaceutical Industries: Business Segmentation
Exhibit 47: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2013
Exhibit 48: Teva Pharmaceutical Industries: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 49: Teva Pharmaceutical Industries: Sales by Geography 2013


Enquiry Before Buy
image
Can´t read the image ? refresh here.